ROR1 and neoplasm: Although CAR-T cells recognizing ROR1 elicited strong cytotoxicity in tumor cells, toxicity in normal cells expressing low levels of ROR1 was detected92,112,116, and further evidence of safety and efficacy are needed prior to the application of ROR1 CAR-T cells.